BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1372740)

  • 1. Reduced pancreatic content of the inhibitory neurotransmitter galanin in genetically obese, hyperinsulinemic mice.
    Dunning BE; Ahrén B
    Pancreas; 1992; 7(2):233-9. PubMed ID: 1372740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse.
    Dunning BE; Ahrén B
    Acta Physiol Scand; 1993 Oct; 149(2):215-9. PubMed ID: 7505518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: strain and sex differences.
    Timmers K; Coleman DL; Voyles NR; Powell AM; Rökaeus A; Recant L
    Metabolism; 1990 Apr; 39(4):378-83. PubMed ID: 1691431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin release during pancreatic nerve stimulation is sufficient to influence islet function.
    Dunning BE; Taborsky GJ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E191-8. PubMed ID: 2463765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic and extrapancreatic galanin release during sympathetic neural activation.
    Dunning BE; Havel PJ; Veith RC; Taborsky GJ
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E436-44. PubMed ID: 1690516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets.
    Ahrén B; Ar'Rajab A; Böttcher G; Sundler F; Dunning BE
    Cell Tissue Res; 1991 May; 264(2):263-7. PubMed ID: 1715240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
    Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM
    Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corelease of galanin and NE from pancreatic sympathetic nerves during severe hypoglycemia in dogs.
    Havel PJ; Mundinger TO; Veith RC; Dunning BE; Taborsky GJ
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E8-16. PubMed ID: 1379000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of galanin to stress-induced impairment of insulin secretion in swimming mice.
    Dunning BE; Karlsson S; Ahrén B
    Acta Physiol Scand; 1991 Oct; 143(2):145-52. PubMed ID: 1720596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice.
    Starich GH; Zafirova M; Jablenska R; Petkov P; Lardinois CK
    Acta Histochem; 1991; 90(1):93-101. PubMed ID: 1675542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
    Berelowitz M; Coleman DL; Frohman LA
    Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice.
    Dubuc PU
    Metabolism; 1976 Dec; 25(12):1567-74. PubMed ID: 994838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice.
    Okuda T; Romsos DR
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):801-5. PubMed ID: 7894518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin: a novel pancreatic neuropeptide.
    Dunning BE; Ahren B; Veith RC; Böttcher G; Sundler F; Taborsky GJ
    Am J Physiol; 1986 Jul; 251(1 Pt 1):E127-33. PubMed ID: 2425633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone-releasing hormone on the secretion of islet hormones and on glucose homeostasis in lean and genetically obese-diabetic (ob/ob) mice and normal rats.
    Bailey CJ; Wilkes LC; Flatt PR; Conlon JM; Buchanan KD
    J Endocrinol; 1989 Oct; 123(1):19-24. PubMed ID: 2572664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
    Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR
    Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice.
    Sheppard MC; Bailey CJ; Flatt PR; Swanston-Flatt SK; Shennan KI
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):532-6. PubMed ID: 3887830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
    Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
    Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.